Obesity is a chronic, relapsing neurochemical disease

International Journal of Obesity

Volumn 28, Issue 1, 2004, Pages 34-38

  Bray, G A ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Etiology; Leptin; Treatments

Indexed keywords

LEPTIN;

ANALYTIC METHOD; ANTHROPOMETRY; BODY MASS; BODY WEIGHT; CHRONIC DISEASE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ENERGY METABOLISM; FEMALE; HUMAN; HYPERTENSION; MALE; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE; REVIEW; RISK FACTOR;

BODY WEIGHT; CHRONIC DISEASE; ENERGY METABOLISM; FEMALE; HUMANS; LEPTIN; MALE; OBESITY; RECURRENCE; RISK FACTORS;

EID: 0942268782     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802479     Document Type: Review

References (36)

1. Heshka S, Allison DB. Is obesity a disease? Int J Obes Relat Metab Disord 2001; 25: 1401-1404.
2. Downey M. Obesity as a disease entity. Am Heart J 2001; 142: 1091-1094.
3. Fine JT, Colditz GA, Coakley EH, Moseley G, Manson JE, Willett WC, Kawachi I. A prospective study of weight change and health-related quality of life in women. JAMA 1999; 282: 2136-2142.
4. Coakley EH, Rimm EB, Colditz G, Kawachi I, Willett W. Predictors of weight change in men: results from the Health Professionals Follow-up Study. Int J Obes Relat Metab Disord 1998; 22: 89-96.
5. Bray GA. Obesity: Historical development of scientific and cultural ideas. Int J Obes Relat Metab Disord 1990; 14: 909-926.
6. Flemyng M. A discourse on the nature, causes, and cure of corpulency, [illustrated by a remarkable case, read before the Royal Society, November 1757]. L. Davis and C. Reymers: London; 1760.
7. Wadd W. Cursory remarks on CORPULENCE; by a member of the Royal College of Surgeons [William Wadd, Surgeon]. J. Callow, Medical Bookseller: London; 1810.
8. Babinski JFF. Tumeur du corps pituitaire sans acromegalie et avec arret de developpement des organes genitaux. Rev Neurol 1900; 8: 531-533.
9. Frohlich A. Ein Fall von Tumor der Hypophysis cerebri ohne Akromegalie. Wien klin Rundschau 1901; 15: 883-886, 906-908.
10. Duffin J. History of medicine. University of Toronto Press: Toronto; 1999.
11. Faber K. Nosography in modern internal medicine. Paul B. Hoeber Inc.: New York; 1923.
12. Bray GA. Drug treatment of obesity: don't throw the baby out with the bath water. Am J Clin Nutr 1998; 67: 1-4, [editorial].
13. von Helmholtz H. Uber die Erhaltung der Kraft. G. Reimer: Berlin; 1847.
14. Atwater WO, Benedict FG. Experiments on the metabolism of matter and energy in the human body, 1899-1900. Government Printing Office: Washington; 1902. U.S. Department of Agriculture, Office of Experiment Stations Bulletin No. 109.
15. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
16. Guy-Grand B, Apfelbaum M, Crepaldi G, Gries A, Lefebvre P, Turner P. International trial of long-term dexfenfluramine in obesity. Lancet 1989; 2: 1142-1145.
17. Schwartz MW, Woods SC, Porte Jr D, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000; 404: 661-671.
18. Tecott LH, Sun LM, Akana SF, Strack AM, Lowenstein DH, Dallman MF, Julius D. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 1995; 374: 542-546.
19. Bray GA, Greenway FL. Current and potential drugs for treatment for obesity. Endocr Rev 1999; 20: 805-875.
20. Morgagni JB. De sedibus, et causis morborum per anatomen indagatis Libri Quinque. Dissectiones, et animadversiones, nunc primum editas complectuntur propenodum innumeras, medicis, chirurgis, anatomicia profuturas. Multiplex praefixus est index rerum and nominum accuratissimus. Typographia Remodiniana: Venetiis; 1761.
21. Schwann T. Mikroscopische Untersuchungen uber die Uebereinstimmung in der Struktur un dem Wachsthum der Thiere und Pflanzen. Sander: Berlin; 1839.
22. Virchow R. Die Cellularpathologie in inrer Begrundung auf physiologische and pathologische Gewebelehre. August Hirschwald: Berlin; 1858.
23. Bjurlf P. Atherosclerosis and body build with special reference to size and number of subcutaneous fat cells. Acta Med Scand 1959; 166: 99.
24. Bjorntorp P. Obesity at the cellular level. Nord Med 1991; 106: 191-194, [Review].
25. Hirsch J, Gallian E. Methods for the determination of adipose cell size in man and animals. J Lipid Res 1968; 9: 110-119.
26. Bray GA. An atlas of obesity and weight control. Parthenon Publishing: London; 2003.
27. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, Shulman GI. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 1999; 103: 253-259.
28. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; i: 785-789.
29. Smith SR, Lovejoy JC, Greenway F, Ryan D, deJonge L, de la Bretonne J, Volafova J, Bray GA. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism 2001; 50: 425-435.
30. Hegarty BD, Furler SM, Ye J, Cooney GJ, Kraegen EW. The role of intramuscular lipid in insulin resistance. Acta Physiol Scand 2003; 178: 373-383.
31. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557-1565.
32. Quetelet A. Sur l'homme et le developpement de ses facultes, ou essai de physique sociale. Bachelier: Paris; 1835.
33. Bray GA. Contemporary diagnosis and management of obesity and the metabolic syndrome, 2nd edn Handbooks in Health Care: Newtown, PA; 2003.
34. National Cholesterol Education Program. Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
35. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359.
36. Rankinen T, Perusse L, Weisnagel SJ, Snyder EE, Chagnon YC, Bouchard C. The human obesity gene map: the 2001 update. Obes Res 2002; 10: 196-243, [Review].